The company’s FDA-approved biologic, NexoBrid®, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the U.S., European Union, Japan, and other international ...

Presentations at WHS and SAWC to highlight EscharEx's mechanism of action, preclinical advantages over SANTYL®, and new data in treating V ...

Typical lesions progress from red or gray macules or papules, to red or gray macules or papules with a central eschar or ulceration. This evolution is a consequence of the thrombosis of dermal ...

the scald burns epithelialized twice as rapidly and with less eschar formation. [45] Other silicone products from this company include a silicone tape, silicone foam dressings, and cotton ...